Explore Past Issues of MedTech Strategist

With more than 100 years of collective experience, our subject matter experts have designed MedTech Strategist as an indispensable resource for you, and your entire organization.

MedTech Strategist has published an impressive 89 issues and nearly 650 articles.

Think Strategically.  Subscribe Today.


Issue: Vol. 6, No. 8, May 30, 2019

  • “Information as Medicine,” by Mary Stuart

  • “MedTecX: Mining China’s Appetite for New Technology,” by David Cassak

  • “3D Printing’s Future in Orthopedics: The Who, What, When, Where, and Why,” by Paula Ness Speers, Masha Dumanis, Brandon Wade and Matthew Barnes, Health Advances, and Aenor Sawyer, MD

  • “IPO Window Remains Open, But M&A Slows—Are Valuations Getting Too Frothy?” by Stephen Levin

  • Start-Ups to Watch—"Axon Therapies: A Physiologic Intervention for Heart Failure Patients with HfpEF,“ by Mary Stuart

  • Start-Ups to Watch—"Conformal Medical: Simpler, Safer Left Atrial Appendage Occlusion,” by Mary Stuart


Issue: Vol. 6, No. 7, May 15, 2019

  • “LEO Science & Tech Hub: A New Model for Cross-Industry Innovation,” by Mary Stuart

  • “Hot Topics in Cardiovascular Devices: A Conversation with Michael John,” by Mary Thompson

  • “Orthopedic ASC Market Growth Inevitable, Despite CMS TKA Ruling,” by Wendy Diller

  • Start-Ups to Watch— “Platelet BioGenesis: Getting Platelets to Patients on Time and at Cost,” by Wendy Diller

  • Start-Ups to Watch— “Sana Health: Pain Relieved, Not Just Masked,” by Colin Miller

  • Start-Ups to Watch— “Sonavex: Post-Op Monitoring in Three Dimensions,” by Colin Miller


Issue: Vol. 6, No. 6, April 24, 2019

  • “Mynosys and the Science of Market Penetration: A Case Study from Navigant Consulting,” by Michelle D. Edwards and Mary Stuart

  • “J&J Bets Big in Robotic Surgery,” by David Cassak

  • “Applying Regenerative Medicine, Stavros Thomopoulos Tackles the Challenges of Tendon-to-Bone Healing,” by Wendy Diller

  • “Boston Scientific Aims High in Oncology,” by Mark Ratner

  • “Why Cancer Precision Medicine is Relevant to the Device Industry,” by Wendy Diller

  • Start-Ups to Watch— “Reactive Robotics: In the ICU, Robots Enable the Human Touch,” by Mary Stuart

  • Start-Ups to Watch— “Zeto: Sensing Improvement in Neurological Data Processing,” by Colin Miller


Issue: Vol. 6, No. 5, April 3, 2019

  • “Biodesign Bridges the Gender Gap,” by David Cassak

  • “Diabetes: Technology Advances Redefine the Standard of Care,” by Mary Thompson

  • “Farshid Guilak is Betting 3D Biofabrics, Smart Cells, and Drug-Device Combinations Can Fight Osteoarthritis,” by Wendy Diller

  • “Can Innovative Value-Based Pricing Models Relieve Pricing Pressure in the Medical Device Industry?” by Matthew Majewski and Kira Gordon, CRA

  • Start-Ups to Watch— “Reprieve Cardiovascular: Improving the Front-Line Therapy for Acute Decompensated Heart Failure,” by Mary Stuart

  • Start-Ups to Watch— “Vasotorq: Catching Clots Quicker,” by Colin Miller


Issue: Vol. 6, No. 4, March 13, 2019

  • “The Future of Medical Device Innovation,” by David Cassak

  • “Will Heart Failure Be the Next Growth Market in Transcatheter Structural Heart?” by Mary Stuart

  • “As Some VCs Exit Medtech, Others Spot Opportunity,” by Melanie Senior

  • “Cornell’s Lawrence Bonassar’s Efforts to Scale 3D-Printed Biomaterials,” by Wendy Diller

  • “Good Year for IPOs and M&A Looks to Continue, Slowed Only by Government Shutdown,” by Stephen Levin

  • Start-Ups to Watch— “Salvia BioElectronics: A Neurostimulation Platform for Migraine,” by Mary Stuart

  • Start-Ups to Watch— “TAS Medical: Putting Laparoscopic Hernia Repair in the Lead,” by Colin Miller


Issue: Vol. 6, No. 3, February 20, 2019

  • “Will Allurion’s Gastric Balloon Platform Grow the Obesity Market?” by Mary Stuart

  • “Innogest and the Virtues of Focused Investing,”  by David Cassak

  • “OpGen’s Bet on Precision Antibiotics,” by Wendy Diller

  • Start-Ups to Watch—"Magnolia Medical: A Simple Solution With a Big Impact on Blood Draw Contamination,” by Wendy Diller

  • Start-Ups to Watch—"NightWare: Putting Nightmare Disorder to Rest,” by Colin Miller


Issue: Vol. 6, No. 2, January 30, 2019

  • “Was Theranos a Cautionary Tale for Medtech?” by David Cassak

  • “Hello Pharma? Diabetes is Calling; How Eli Lilly is Leveraging Digital Diabetes Device Technologies to Help Grow its Future,” by Mary Thompson

  • “The Challenge of Pediatric Device Development,” by Bridget Shaia & Andrew Millar

  • “Mayo Clinic’s Eko Partnership Typifies its Approach to AI Innovation,” by Mark Ratner

  • Start-Ups to Watch— “AMB Surgical II: Getting Smart About Pediatric Orthopedics,” by Colin Miller

  • Start-Ups to Watch— “Ōmcare: Ensuring Drug Adherence, Assuring Caregivers,” by Colin Miller


Issue: Vol. 6, No. 1, January 16, 2019

  • “Is the Medtech Industry Evil?” by David Cassak

  • “Digital Health is Taking Off Among Providers: What Could that Mean for Orthopedics?” by Wendy Diller

  • “Intuitive Faces the Future of Surgical Robotics,” by David Cassak

  • “Vytronus Poised to Offer the First Personalized Therapy Approach to Cardiac Ablation,” by Mary Stuart

  • Start-Ups to Watch— “Inscope Medical Solutions: Laryngoscopy Leveled Up,” by Colin Miller

  • Start-Ups to Watch— “Virtuoso Surgical: Empowering Endoscopic Surgery,” by Colin Miller


Issue: Vol. 5, No. 17, December 19, 2018

  • “Intuitive Surgical: As Robotics Heats Up, Can the Market Leader Stay Ahead of the Pack?” by David Cassak

  • “Next-Gen Technologies Aim to Reform the Microbiology Lab, But Do They Pose Significant Threats to the Big Guys?” by Wendy Diller

  • “Portfolia’s FemTech Fund Activates a New Source of Investors: Women,” by Mary Stuart

  • “Financing Reversal of Fortune as IPOs Out-Pace M&A,” by Stephen Levin

  • “Medtech vs. Pharma: Will Digital Bridge the Culture Gap?” by Melanie Senior

  • Start-Ups to Watch— “Adagio Medical: Lowering Temperatures, Raising Bars,” by Colin Miller

  • Start-Ups to Watch— “Madorra: A New, Non-hormonal, Noninvasive Solution for Vaginal Tissue Health,” by Mary Stuart


Issue: Vol. 5, No. 16, November 26, 2018

  • “China and the Value of Speed to Scale,” by David Cassak

  • “Breaking Sound Barriers in the Hearing Aid Market,” by Mary Stuart

  • “mSToPS: How Digital Wearables Could Enable Less Costly, More Real-World Clinical Trials - A Conversation with Steven Steinhubl, MD,” by Mary Thompson

  • “At NASS 2018, Advanced Biomaterials and the Pull of Robots,” by Wendy Diller

  • Start-Ups to Watch— “Omniscient: Increasing Adenoma Detection Rates during Screening Colonoscopy,” by Mary Stuart

  • Start-Ups to Watch— “Predigen: Predictive Host Response Genomics for Early Diagnosis of Disease,” by Wendy Diller


Issue: Vol. 5, No. 15, October 31, 2018

  • “Ambulatory ECG Monitoring Enters a New, More Patient-Friendly Era: Digital Technologies Shake Up Arrhythmia Monitoring, Part 2,” by Mary Thompson

  • “The Magic of Innovation: An Interview with William Cohn, MD,” by David Cassak

  • “Do Wearables Have a Medical Role in Orthopedics?” by Wendy Diller

  • Start-Ups to Watch—"Augmedics: Augmented Reality Offers Intuitive Surgical Navigation,” by Mary Stuart

  • Start-Ups to Watch—"OtoNexus Medical Technologies, Inc.: Eliminating Uncertainty from Ear Exams,” by Colin Miller


Issue: Vol. 5, No. 14 - October 17, 2018

  • “MD Start: Building Medtech Companies in Europe,” by David Cassak

  • “Regulatory Shifts for HCT/P Products Put Orthobiologics Manufacturers on the Spot,” by Wendy Diller

  • SIDEBAR: “FDA’s Evolving Criteria for Tissue-based Biologics: Takeaways,” by Wendy Diller

  • SIDEBAR: “MiMedx Wins an Orthopedic Rarity: RMAT Designation for AmnioFix Injectable, “ by Wendy Diller

  •  “Three Strategies to Avoid Medical Device Commoditization,” by Tom Dudnyk, VIVO Agency

  • Start-Ups to Watch—"EmboMedics: Thinking Organically about Embolization,” by Colin Miller

  • Start-Ups to Watch—"Kobara Medical: Epicardial Pacing Provides Advantages for Heart Failure Patients,” by Mary Stuart


Issue: Vol. 5, No. 13 - September 28, 2018

  • “SpineGuard: Riding Robotics’ Wave,” by David Cassak

  • “Atrial Fibrillation Part 2: New Mapping, Information Systems Lay Down Evidence Base,” by Mary Stuart

  • SIDEBAR: “Kardium Tackles the AF Problem from Scratch,” by Mary Stuart

  • “Digital Taps Into Neurological Function,” by Mark Ratner

  • “Digital Technologies Shake Up Arrhythmia Monitoring, Part 1: Apple’s New ECG-Enabled Watch—Gizmo or Game Changer?” by Mary Thompson

  • Start-Ups To Watch —“PathMaker Neurosystems: A Non-Invasive Bioelectronic Platform Restores Neuromotor Function,” by Mary Stuart

  • Start-Ups To Watch — “Perflow Medical: Next-Gen Products for a Booming Neurovascular Market,” by Mary Stuart


Issue: Vol. 5, No. 12 - September 14, 2018

  • “Orthobiologics at a Crossroads,” by Wendy Diller

  • SIDEBAR: “KOA Clinical Trials May Soon Provide Some Insights,” by Wendy Diller

  • “ CGM on the Upswing: A Three-Month Implantable Enters the Fray,” by Mary Thompson

  • SIDEBAR: “Senseonics Expands the CGM Toolbox with a 90-Day Implantable: CEO Tim Goodnow Charts the Path Forward” by Mary Thompson

  • “Is Medtech Too White?” By Kwame Ulmer

  • Start-Ups To Watch - “Neuromod Devices: Targeting Tinnitus Discreetly and Effectively,” by Colin Miller

  • Start-Ups To Watch - “Transverse Medical: Total Protection for the Brain During TAVR,” by Mary Stuart  


Issue: Vol. 5, No. 11 - August 24, 2018

  • “As the Digital Revolution Sweeps Healthcare, Don’t Shortchange IVD,” by Wendy Diller

  • “Carbon: Bringing a Revolution to the 3D Revolution,” by David Cassak + Sidebar:  “A Play for Johnson & Johnson”

  • “Atrial Fibrillation Ablation After CABANA: What Are We Missing?,” by Mary Stuart + Sidebar: “CABANA Results in Confusion, Not Clarity”

  • “Companies See Big Opportunity for AI-Assisted Imaging in Stroke,”  by Varun Saxena

  • “Medtech US IPO Window Finally Re-opens; Financial Buyers Return to M&A Market,” by Stephen Levin

  • Start-Ups To Watch - “AblaCare: Infertility Treatment Made Safer,” by Colin Miller

  • Start-Ups To Watch - “Carmentix:  A Biomarker-Based Approach to the Global Problem of Preterm Births,” by Mary Stuart


Issue: Vol. 5, No. 10 - July 26, 2018

  • In Memoriam— “Sami Hamadé: Medtech Coach, Inspiration, and Investor,” by David Cassak

  • Executive Interviews - “Finding Success in China: The Biosensors Story,” by David Cassak

  • Reproductive Medicine - “How Genomics, Big Data, and Consumerism are Bringing Entrepreneurial Opportunities to Infertility,” by Wendy Diller

  • Digital Health - “Virtual Reality Enters Physician Training: A Conversation with Sandra Humbles and David Badri of the Johnson & Johnson Institute,” by Mary Thompson

  • Outside Opinion - “Beware the Seductions of M&A,” by Mark Speers, Health Advances

  • Start-Ups to Watch – “Neurent Medical: An Office-Based Procedure Treats Rhinitis,” by Mary Stuart

  • Start-Ups to Watch—“Univfy: Personalized Prognostics for Successful, Accessible IVF Treatment,” by Wendy Diller

 


Issue: Vol. 5, No. 9 - June 27, 2018

  • “Charting Baxter International Inc.’s Rebound: An Interview with CEO Joe Almeida,” by David Cassak

  • “Orthopedics Grapples with Evidence-Based Use of Stem-Cell Therapies,” by Wendy Diller

  • “Good News, Bad News: Hospitals Want to Partner,” by L.E.K. Consulting's Jonas Funk, Monish Rajpal, and Ilya Trakhtenberg

  • “Driving Medical Device Sales and Profit Growth by Creating Mega-5’s,” by John Larson

  • Start-Ups To Watch – “ Output Medical, Inc.: Predicting Acute Kidney Injury Right on Time,” by Colin Miller

  • Start-Ups To Watch – “SentiAR: Intraprocedural, Real-Time Augmented Reality Enhances Catheter Ablation,” by Mary Stuart


Issue: Vol. 5, No. 8 - June 8, 2018

  • Managing in Interesting Times: An Interview with Paul LaViolette,” by David Cassak

  • “In Medtech, Real-World Evidence is Moving Beyond Theory to Regulatory Use,” by Wendy Diller

  • “ResMed Using Digital Health to Fuel a Medtech Growth Strategy,” Mary Stuart

  • “Digital Innovation: Consumer Activation Comes of Age in Medtech,” by Ajay Gupta, Karen Passmore, Sundar Ganapathy, and Chris Smith

  • “What’s Next for the Ischemic Stroke Market? Brett Wall, SVP and President of Brain Therapies at Medtronic, Weighs In,” by Mary Thompson

  • Start-Ups To Watch – “Eyenuk, Inc.: Artificial Intelligence Boosts Diabetic Retinopathy Screening by Mary Stuart

  • Start-Ups To Watch - HeartSciences: Artificial Intelligence Improves Frontline Risk Stratification for Heart Diseases,” by Mary Stuart


Issue: Vol. 5, No. 7 - May 29, 2018

  • Perspective – “Funding Gap? What Funding Gap?” by David Cassak

  • Market Disruptors – “Is Amazon’s Healthcare Foray a Threat to the Medtech Market?” by Wendy Diller

  • “Saluda Medical: Will Sensors and Data Disrupt Spinal Cord Stimulation?” by Mary Stuart

  • “Crossing the High-Tech, ‘Wet Science’ Divide” by Wendy Diller

  • “Solving the Prisoner’s Dilemma: Product Innovation, Solutions-Focused Business Models Can Help Counter Declining Medtech ROC” by Yakir Siegal, Glenn Snyder, Myriam Lopez, Lauren Morton

  • Stroke Devices – “Neurovascular Device Market Poised for Growth” by Oded Ben-Joseph and Seth Bensussen

  • Start-Ups To Watch: “CroiValve: Solution for Tricuspid Regurgitation Supports the Native Valve” by Mary Stuart

  • Start-Ups To Watch: “ChromaCode: Disrupting Molecular Diagnostics in the Digital Age” by Wendy Diller


Issue: Vol. 5, No. 6 - May 11, 2018

  • Executive Interview - “ExploraMed: Patient Need, Stakeholder Perspective Guide Solution Design,” by David Cassak

  • Surgical Pain Management - “Spine Surgeons Confront the Opioid Crisis,” by Wendy Diller

  • Q1 M&A/Financing Wrap-Up - “Despite Optimistic Outlook, M&A Dries Up and IPOs Remain Non-Existent,” by Stephen Levin

  • Market Brief: Orthopedics - “Early Q1 Data Shows Pressure on Ortho,” by Wendy Diller

  • Start-Ups To Watch - Tissue Engineering: “ Humacyte’s Bio-engineered Human Blood Vessel Enters Pivotal Trials,” by Mary Stuart

  • Start-Ups To Watch - Peripheral Artery Disease: “XABLECATH LTD Reimagines Peripheral Vascular Care,” by Colin Miller


Issue: Vol. 5, No. 5 - April 20, 2018

  • “Finding Meaningful Value in Medtech: Interview with Alex Gorsky

  • “Navigating New Technologies through Seismic Shifts: Medtech Execs, Investors Weigh In”

  • “Diabetes Devices: The High-Tech Transformation Continues”

  • “Surgical Robotics: The Future is Now”

  • “Coatings Take Center Stage, Scaffolds a Back Seat”

  • “New Data and More Expansive Guidelines Give Ischemic Stroke Market a Push"

  • “MIS Spine: Advances in Visualization, Navigation, and Robotics”

  • “SUs Expand Device Markets for Pain with Peripheral Nerve Stim & Less Invasive Platforms”

  • “Neuros Medical: An Electrical Nerve Block for Chronic Pain”

  • “Neuspera Medical: Least Invasive Platform Increases Attractiveness of Neurostimulation”

  • “VERAFEYE: Improving First-Procedure AF Ablation Success Rates”


Issue: Vol. 5, No. 4 - March 27, 2018

  • “J&J in Medtech: An Interview with CEO, Alex Gorsky”

  • “Why Big Companies Can’t Innovate”

  • “Advanced Tech: A Corporate Incubator”

  • “AI in Healthcare: Applying Sophisticated Analytics to Solve Healthcare’s Biggest Challenges”

  • “Transcatheter Heart Valves: The Year of Big Data”

  • “Opioid Crisis Reframes Device Market for the Treatment of Pain”

  • “Liquid Biopsies: At an Inflection Point?”

  • “Ophthalmic Surgical Device Market: A Mixed Bag"

  • “Raydiant Oximetry: Provides Crucial Comfort for New Mothers”

  • “Infervision: Applying Deep- Learning AI to Imaging Scans to Improve Disease Detection”

  • “Numares Health: Using Physics and Algorithms to Transform Clinical Diagnostics”

  • “ProLung: Risk Stratification Test for Lung Cancer”


Full Issues of MedTech Strategist from 2014-2018


Recently Covered Companies:

Ablation Frontiers Inc., AppliedVR Inc.,  Becton Dickinson & Co., Biosensors International Group Ltd., Biowink GMBH, Blue Sail Medical Co. Ltd., Boston Scientific Corp., CardioMEMS Inc., Certara LP, GE Medical Systems, GenePeeks Inc., Huawe, Illumina Inc., Intersect ENT, Johnson & Johnson, Johnson & Johnson Institute, Johnson & Johnson Medical Devices Companies, Lepu Medical Technology (Beijing) Co. Ltd., Eli Lilly & Co., Medtronic PLC, MicroPort Scientific Corp.,  Mindray Medical International Ltd., Mitsubishi Chemical Holdings Corp., Modern Fertility, Neurent Medical, Nevro Corp., Novartis AG, NxThera Inc., Oculus VR LLC, Prelude Fertility, PuraCath Medical Inc., Samsung Electronics America Inc., Shandong Weigao Group Medical Polymer Co., Shockwave Medical Inc., Terumo Corp., Tusker Medical Inc., Univfy Inc., 23andme Inc., 3D Systems, Abbott Laboratories Inc., AblaCare, Adidas Inc., Aidoc, Align Technology Inc., Ambry Genetics, Angiodynamics Inc., Becton Dickinson & Co., Bioabsorbable Vascular Solutions, BMW, Boston Scientific Corp., Brainomix, Canon Medical Systems, Carbon Inc., CardioFocus Inc., Carmentix Pte. Ltd., Cerebrotech Medical Systems Inc., Cerner Corp., ELectroCore Inc., Farapulse Inc., FormaLabs, GE Healthcare, General Electric Co., Google, Grupo Fleury, Hologic Inc., IBM Watson Health, Imricor Medical Inc., Infervision, Inspire Medical System Inc.,  Intel Corp., Invitae Corp., iSchemaView Inc., Johnson & Johnson, LifeScan Inc., Liquidia Technologies Inc., MakerBot, Max-Q AI, Medtronic PLC, Neuronetics Inc., Orthopediatrics Corp., Penumbra Inc., Qiagen, Rapid Medical, Roche, Roche Diagnostics Corp., Royal Philips, Samsung Neurologica, Sensome, Stratasys, Stryker Corp., Viewics Inc., Viz.ai, Vyaire Medical, WhatsApp, Zebra Medical Vision

Recently Covered Topics:

Cardiovascular; Vascular; Diagnostics; Health Information Technology; Digital Health; Respiratory;  Neurostimulation; Neuromodulation; Ophthalmology; Pain Management; Surgery; Minimally Invasive Surgery; Robotics; Orthopedics; Medtech Business Strategies; Business Development; Executive Interviews; Perspective; Commentary; Imaging; Oncology; Women’s Health; Oncology; Precision Medicine, Spine; Aesthetics/Dermatology; Reimbursement; Regulatory; Healthcare delivery; Providers; Payors, Neurology; Neurovascular; Critical Care; Emergency Medicine; Medical Devices;  Investments; Finance; M&As; Services And Solutions; Start-Ups; Ear, Nose & Throat, Emerging Markets